Status: current, Primitive. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1548691000168117 | Ursodeoxycholic Acid (LAPL) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1548701000168117 | Ursodeoxycholic Acid (LAPL) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ursodeoxycholic Acid (LAPL) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule | Is a | True | Ursodeoxycholic Acid (LAPL) | Inferred relationship | Some | |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60, blister pack | has TP | True | Ursodeoxycholic Acid (LAPL) | Inferred relationship | Some | |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 60 | has TP | True | Ursodeoxycholic Acid (LAPL) | Inferred relationship | Some | |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 100, blister pack | has TP | True | Ursodeoxycholic Acid (LAPL) | Inferred relationship | Some | |
| Ursodeoxycholic Acid (LAPL) 250 mg capsule, 100 | has TP | True | Ursodeoxycholic Acid (LAPL) | Inferred relationship | Some |
Reference Sets
FHIR